Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial (2013)
- Authors:
- USP affiliated authors: HALLAK, JAIME EDUARDO CECILIO - FMRP ; ABRÃO, JOÃO - FMRP ; EVORA, PAULO ROBERTO BARBOSA - FMRP ; ZUARDI, ANTONIO WALDO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP
- Unidade: FMRP
- DOI: 10.1001/jamapsychiatry.2013.1292
- Subjects: ESQUIZOFRENIA; MEDICAÇÃO INTRAVENOSA; ANTIPSICÓTICOS; MÉTODO DUPLO-CEGO; PLACEBOS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: JAMA Psychiatry
- ISSN: 2168-622X
- Volume/Número/Paginação/Ano: v. 70, n. 7, p. 668-676, 2013
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
HALLAK, Jaime Eduardo Cecílio et al. Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial. JAMA Psychiatry, v. 70, n. 7, p. 668-676, 2013Tradução . . Disponível em: https://doi.org/10.1001/jamapsychiatry.2013.1292. Acesso em: 18 abr. 2024. -
APA
Hallak, J. E. C., Maia-de-Oliveira, J. P., Abrão, J., Evora, P. R. B., Zuardi, A. W., Crippa, J. A. de S., et al. (2013). Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial. JAMA Psychiatry, 70( 7), 668-676. doi:10.1001/jamapsychiatry.2013.1292 -
NLM
Hallak JEC, Maia-de-Oliveira JP, Abrão J, Evora PRB, Zuardi AW, Crippa JA de S, Belmonte-de-Abreu P, Baker GB, Dursun SM. Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial [Internet]. JAMA Psychiatry. 2013 ; 70( 7): 668-676.[citado 2024 abr. 18 ] Available from: https://doi.org/10.1001/jamapsychiatry.2013.1292 -
Vancouver
Hallak JEC, Maia-de-Oliveira JP, Abrão J, Evora PRB, Zuardi AW, Crippa JA de S, Belmonte-de-Abreu P, Baker GB, Dursun SM. Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial [Internet]. JAMA Psychiatry. 2013 ; 70( 7): 668-676.[citado 2024 abr. 18 ] Available from: https://doi.org/10.1001/jamapsychiatry.2013.1292 - The effects of sodium nitroprusside treatment on cognitive deficits in schizophrenia. [Carta]: a pilot study
- The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects
- Cannabidiol: an anxiolytic or an antipsychotic new drug?
- Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
- Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizopherenia: an update
- Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implication for neuroprotection
- Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats
Informações sobre o DOI: 10.1001/jamapsychiatry.2013.1292 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
